481 - Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death
| Autor: | Na, R., Zheng, S.L., Han, M., Yu, H., Jiang, D., Shah, S., Ewing, C., Zhang, L., Novakovic, K., Petkewicz, J., Gulukota, K., Helseth, D., Quinn, M., Humphries, E., Wiley, K., Isaacs, S., Wu, Y., Liu, X., Zhang, N., Wang, C.-H., Khandekar, J., Hulick, P., Shevrin, D., Cooney, K., Shen, Z., Partin, A., Carter, H.B., Carducci, M., Eisenberger, M., Denmeade, S., McGuire, M., Walsh, P., Helfand, B., Brendler, C., Ding, Q., Xu, J., Isaacs, W. |
|---|---|
| Zdroj: | In European Urology Supplements March 2017 16(3):e832-e833 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect